Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Larasan Pharmaceutical Corporation was a specialty pharmaceutical company based in Fort Lauderdale, Florida, that focused on the development and commercialization of over-the-counter (OTC) analgesic products. Founded in 2002, the company specialized in nature-based formulations and innovative delivery systems, most notably the FLEX24 Performance Patch and the FLEX24 Pain Pen. These products utilized active ingredients such as camphor and menthol to provide targeted relief for joint pain, muscle aches, and musculoskeletal conditions. The company aimed for global distribution and was supported by a high-profile advisory board, including renowned medical correspondent Dr. Bob Arnot. Larasan Pharmaceutical Corporation maintained a portfolio of several NDC-listed products before undergoing voluntary dissolution in October 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Larasan Pharmaceutical.